Original Research

Published on 08 May 2024

The single-dose Janssen Ad26.COV2.S COVID-19 vaccine elicited robust and persistent anti-spike IgG antibody responses in a 12-month Ugandan cohort

in Vaccines and Molecular Therapeutics

Jennifer Serwanga
Laban Kato
Gerald Kevin Oluka
Violet Ankunda
Jackson Sembera
Claire Baine
Isaac Kitabye
Angela Namuyanja
Solomon Opio
Joseph Ssebwana Katende

Frontiers in Immunology

doi 10.3389/fimmu.2024.1384668

187 views

Original Research

Published on 08 May 2024

Heterologous Ad26/Ad5 adenovirus-vectored vaccines elicited SARS-CoV-2-specific antibody responses with potent Fc activities

in Vaccines and Molecular Therapeutics

Jéromine Klingler
Shreyas Kowdle
Juan C. Bandres
Rozita Emami-Gorizi
Raymond A. Alvarez
Priyanka G. Rao
Fatima Amanat
Charles Gleason
Giulio Kleiner
Viviana Simon

Frontiers in Immunology

doi 10.3389/fimmu.2024.1382619

124 views

Original Research

Published on 08 May 2024

BacScan: a novel genome-wide strategy for uncovering broadly immunogenic proteins in bacteria

in Vaccines and Molecular Therapeutics

Junhua Dong
Qian Zhang
Jinyue Yang
Yacan Zhao
Zhuangxia Miao
Siyang Pei
Huan Qin
Changwei Jing
Guoyuan Wen
Anding Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1392456

114 views

Original Research

Accepted on 07 May 2024

Deletion of an immune evasion gene, steD, from a live Salmonella enterica serovar Typhimurium vaccine improves vaccine responses in aged mice

in Vaccines and Molecular Therapeutics

Jessica Allen
Shanaliz S Natta
Shamima Nasrin
Franklin R Toapanta
Sharon Tennant

Frontiers in Immunology

doi 10.3389/fimmu.2024.1376734

Original Research

Published on 07 May 2024

Distinct T cell responsiveness to different COVID-19 vaccines and cross-reactivity to SARS-CoV-2 variants with age and CMV status

in Vaccines and Molecular Therapeutics

Jolanda Brummelman
Sara Suárez-Hernández
Lia de Rond
Marjan Bogaard-van Maurik
Petra Molenaar
Emma van Wijlen
Debbie Oomen
Lisa Beckers
Nynke Y. Rots
Josine van Beek

Frontiers in Immunology

doi 10.3389/fimmu.2024.1392477

350 views

Original Research

Accepted on 06 May 2024

Synthetic BSA-Conjugated Disaccharide Related to the Streptococcus pneumoniae Serotype 3 Capsular Polysaccharide Increases IL-17A Levels, γδ T Cells, and B1 Cells in Mice

in Vaccines and Molecular Therapeutics

Ekaterina A Kurbatova
Nelli Akhmatova
Anton E Zaytsev
Elina Akhmatova
Natalya E Yastrebova
Elena V Sukhova
Dmitriy V Yashunsky
Yury Tsvetkov
Nikolay E. Nifantiev

Frontiers in Immunology

doi 10.3389/fimmu.2024.1388721

Original Research

Accepted on 02 May 2024

The extracellular serine protease from Staphylococcus epidermidis elicits a type 2-biased immune response in atopic dermatitis patients

in Vaccines and Molecular Therapeutics

Goran Abdurrahman
Rebecca Pospich
Leif Steil
Manuela Gesell Salazar
Juan José Izquierdo González
Nicole Normann
Daniel Mrochen
Christian Scharf
Uwe Völker
Thomas Werfel

Frontiers in Immunology

doi 10.3389/fimmu.2024.1352704

Original Research

Published on 02 May 2024

Long-term humoral and cellular immunity against vaccine strains and Omicron subvariants (BQ.1.1, BN.1, XBB.1, and EG.5) after bivalent COVID-19 vaccination

in Vaccines and Molecular Therapeutics

Hakjun Hyun
Eliel Nham
Hye Seong
Jin Gu Yoon
Ji Yun Noh
Hee Jin Cheong
Woo Joo Kim
Sun Kyung Yoon
Se-Jin Park
WonSeok Gwak

Frontiers in Immunology

doi 10.3389/fimmu.2024.1385135

296 views

Perspective

Published on 02 May 2024

Protecting the vulnerable: addressing the COVID-19 care needs of people with compromised immunity

in Vaccines and Molecular Therapeutics

Raymund R. Razonable

Frontiers in Immunology

doi 10.3389/fimmu.2024.1397040

239 views

Original Research

Accepted on 01 May 2024

Antibody responses in blood and saliva post COVID-19 bivalent booster do not reveal an Omicron BA.4/BA.5-specific response

in Vaccines and Molecular Therapeutics

Ryan Baker
Rebecca Lawlor
Maeve Smith
Jessica Price
Ashley Eaton
Andrew Lover
Dominique Alfandari
Peter Reinhart
Kathleen Arcaro
Barbara A Osborne

Frontiers in Immunology

doi 10.3389/fimmu.2024.1401209

Original Research

Published on 01 May 2024

Antibodies to Aedes aegypti D7L salivary proteins as a new serological tool to estimate human exposure to Aedes mosquitoes

in Vaccines and Molecular Therapeutics

Sophana Chea
Laura Willen
Sreynik Nhek
Piseth Ly
Kristina Tang
James Oristian
Roberto Salas-Carrillo
Aiyana Ponce
Paola Carolina Valenzuela Leon
Dara Kong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1368066

606 views

Original Research

Accepted on 30 Apr 2024

Immunization with PfGBP130 generates antibodies that inhibit RBC invasion by P. falciparum parasites

in Vaccines and Molecular Therapeutics

Jonathan David Kurtis
Yannick Johnson
Ahmad Rushdi Shakri
Sunthorn Pond-Tor
Anup Jnawali
Tanbir Najrana
Hannah Wei Wu
Mohamad-Gabriel Alameh
Drew Weissman
EDWARD KABYEMELA

Frontiers in Immunology

doi 10.3389/fimmu.2024.1350560

Brief Research Report

Accepted on 30 Apr 2024

Seasonal coronavirus (HCoV) humoral responses in AZD1222 (ChaAdOx1 nCoV-19) COVID-19 vaccinated adults reveal limited cross-immunity

in Vaccines and Molecular Therapeutics

Ann Marie Stanley
Anastasia A Aksyuk
Deidre Wilkins
Justin A Green
Dongmei Lan
Kathryn Shoemaker
Hong-Van Tieu
Magdalena E Sobieszczyk
Ann R Falsey
Elizabeth J Kelly

Frontiers in Immunology

doi 10.3389/fimmu.2024.1401728

Original Research

Published on 30 Apr 2024

A universal recombinant adenovirus type 5 vector-based COVID-19 vaccine

in Vaccines and Molecular Therapeutics

Xingxing Li
Qinhua Peng
Xinyu Liu
Hongshan Xu
Jingjing Liu
Xiaohong Wu
Qiang Ye
Min Li
Yuhua Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1374486

351 views

Original Research

Published on 30 Apr 2024

A two-dose viral-vectored Plasmodium vivax multistage vaccine confers durable protection and transmission-blockade in a pre-clinical study

in Vaccines and Molecular Therapeutics

Yutaro Yamamoto
Camila Fabbri
Daiki Okuhara
Rina Takagi
Yuna Kawabata
Takuto Katayama
Mitsuhiro Iyori
Ammar A. Hasyim
Akihiko Sakamoto
Hiroaki Mizukami

Frontiers in Immunology

doi 10.3389/fimmu.2024.1372584

401 views

Original Research

Published on 30 Apr 2024

Isolation and characterization of Hc-targeting chimeric heavy chain antibodies neutralizing botulinum neurotoxin type B

in Vaccines and Molecular Therapeutics

Yujia Jiang
Rong Wang
Jiazheng Guo
Kexuan Cheng
Lei Chen
Xi Wang
Yating Li
Peng Du
Chen Gao
Jiansheng Lu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1380694

203 views

Navigation group

Articles

The single-dose Janssen Ad26.COV2.S COVID-19 vaccine elicited robust and persistent anti-spike IgG antibody responses in a 12-month Ugandan cohort

Heterologous Ad26/Ad5 adenovirus-vectored vaccines elicited SARS-CoV-2-specific antibody responses with potent Fc activities

BacScan: a novel genome-wide strategy for uncovering broadly immunogenic proteins in bacteria

Deletion of an immune evasion gene, steD, from a live Salmonella enterica serovar Typhimurium vaccine improves vaccine responses in aged mice

Distinct T cell responsiveness to different COVID-19 vaccines and cross-reactivity to SARS-CoV-2 variants with age and CMV status

Synthetic BSA-Conjugated Disaccharide Related to the Streptococcus pneumoniae Serotype 3 Capsular Polysaccharide Increases IL-17A Levels, γδ T Cells, and B1 Cells in Mice

The extracellular serine protease from Staphylococcus epidermidis elicits a type 2-biased immune response in atopic dermatitis patients

Long-term humoral and cellular immunity against vaccine strains and Omicron subvariants (BQ.1.1, BN.1, XBB.1, and EG.5) after bivalent COVID-19 vaccination

Protecting the vulnerable: addressing the COVID-19 care needs of people with compromised immunity

Antibody responses in blood and saliva post COVID-19 bivalent booster do not reveal an Omicron BA.4/BA.5-specific response

Antibodies to Aedes aegypti D7L salivary proteins as a new serological tool to estimate human exposure to Aedes mosquitoes

Immunization with PfGBP130 generates antibodies that inhibit RBC invasion by P. falciparum parasites

Seasonal coronavirus (HCoV) humoral responses in AZD1222 (ChaAdOx1 nCoV-19) COVID-19 vaccinated adults reveal limited cross-immunity

A universal recombinant adenovirus type 5 vector-based COVID-19 vaccine

A two-dose viral-vectored Plasmodium vivax multistage vaccine confers durable protection and transmission-blockade in a pre-clinical study

Isolation and characterization of Hc-targeting chimeric heavy chain antibodies neutralizing botulinum neurotoxin type B